Biotechnology and health care stocks and ETFs continue to lead the market. This is becoming a dominant theme within the broad technology sector. It is likely that health care and biotechnology stocks continue to grow in relative market cap weight in the major US indices (i.e. NASDAQ 100 & S&P 500).
